TickerFacts.

Biomerica Inc (BMRA): EPS (Basic)

Annual figures by period end, from SEC filings.

Stock splits: 1-for-8, first reflected in a filing dated 2025-08-29. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-05-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$1.30
Year ended 2026-05-31
$0.082011-05-31: $0.022012-05-31: $0.082013-05-31: $0.082014-05-31: -$0.032015-05-31: -$0.042016-05-31: -$0.202017-05-31: -$0.112018-05-31: -$0.172019-05-31: -$0.262020-05-31: -$0.262021-05-31: -$0.622022-05-31: -$0.362023-05-31: -$0.502024-05-31: -$2.842025-05-31: -$2.162026-05-31: -$1.30-$1.30
2011-05-31 EPS (Basic) (USD per share) 2026-05-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedEPS (Basic)Change YoYSource filing
2026-05-31-$1.30n/m2026-08-31, From 2025-06-01
2025-05-31-$2.16n/m2026-08-31, From 2024-06-01
2024-05-31-$2.84n/c2025-08-29, From 2023-06-01
2023-05-31-$0.50n/m2024-08-28, From 2022-06-01
2022-05-31-$0.36n/m2023-08-25, From 2021-06-01
2021-05-31-$0.62n/m2022-08-29, From 2020-06-01
2020-05-31-$0.26n/c2021-10-14, From 2019-06-01
2019-05-31-$0.26n/m2020-08-31, From 2018-06-01
2018-05-31-$0.17n/m2019-08-29, From 2017-06-01
2017-05-31-$0.11n/m2018-08-29, From 2016-06-01
2016-05-31-$0.20n/m2017-08-29, From 2015-06-01
2015-05-31-$0.04n/m2016-08-29, From 2014-06-01
2014-05-31-$0.03n/m2015-08-31, From 2013-06-01
2013-05-31$0.080.0%2014-08-29, From 2012-06-01
2012-05-31$0.08+300.0%2013-08-29, From 2011-06-01
2011-05-31$0.02n/a2012-08-29, From 2010-06-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
Biomerica Inc (BMRA)2026-05-31-$1.30n/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$1.65n/m
Anbio Biotechnology (NNNN)2025-12-31$0.15+162.5%
Aspira Women's Health Inc. (AWHL)2025-12-31-$0.37n/m
Celldex Therapeutics, Inc. (CLDX)2025-12-31-$3.90n/m
Immucell Corp (ICCC)2025-12-31-$0.12n/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$0.32n/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$3.81n/m
Myriad Genetics Inc (MYGN)2025-12-31-$3.95n/m

Compare BMRA, IMDX, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗